Cargando…

Upregulation of Versican Associated with Tumor Progression, Metastasis, and Poor Prognosis in Bladder Carcinoma

OBJECTIVE: This work analyzes the role of versican (VCAN) on bladder cancer (BLCA). Versican (VCAN) is a chondroitin sulfate proteoglycan which is important for tumorigenesis and the development of cancer. However, the expression of VCAN on human bladder cancer (BLCA) has been rarely reported. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qi, Wu, Junxiu, Chen, Xinpeng, Zhao, Ming, Zhang, Dahong, Gao, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872746/ https://www.ncbi.nlm.nih.gov/pubmed/33604385 http://dx.doi.org/10.1155/2021/6949864

Ejemplares similares

Versican and Tumor-Associated Macrophages Promotes Tumor Progression and Metastasis in Canine and Murine Models of Breast Carcinoma
por: dos Reis, Diego Carlos, et al.
Publicado: (2019)

Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2015)

Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids
por: Desjardins, Mark, et al.
Publicado: (2014)

Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer
por: Song, Junquan, et al.
Publicado: (2022)

Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma
por: Zhao, Jing, et al.
Publicado: (2019)

CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer
por: Zhang, Xiao‐Guang, et al.
Publicado: (2018)

Interleukin-11 Promotes the Progress of Gastric Carcinoma via Abnormally Expressed Versican
por: Zhang, Zhenwei, et al.
Publicado: (2012)

Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

Sharpin promotes hepatocellular carcinoma progression via transactivation of Versican expression
por: Tanaka, Y, et al.
Publicado: (2016)

Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression
por: de Wit, Meike, et al.
Publicado: (2017)

Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2016)

KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma
por: Tan, Hai-Song, et al.
Publicado: (2017)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis
por: Cui, Yifeng, et al.
Publicado: (2019)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Cancer metastasis and EGFR signaling is suppressed by amiodarone-induced versican V2
por: Lee, Hung-Chieh, et al.
Publicado: (2015)

Upregulation of AKIP1 contributes to metastasis and progression and predicts poor prognosis of patients with colorectal cancer
por: Jiang, Weifang, et al.
Publicado: (2018)

HLA complex P5 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma
por: Wang, Yaqin, et al.
Publicado: (2022)

Correction: High LINC01605 expression predicts poor prognosis and promotes tumor progression via upregulation of MMP9 in bladder cancer
Publicado: (2020)

Retraction: High LINC01605 expression predicts poor prognosis and promotes tumor progression via upregulation of MMP9 in bladder cancer
Publicado: (2021)

Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis
por: Asano, Keiichi, et al.
Publicado: (2017)

Inflammation Amplification by Versican: The First Mediator
por: Zhang, Zhenwei, et al.
Publicado: (2012)

Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis
por: Dai, Longfei, et al.
Publicado: (2019)

Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma
por: Zhang, Yingying, et al.
Publicado: (2020)

Prognostic significance of Versican expression in gastric adenocarcinoma
por: Shen, X-H, et al.
Publicado: (2015)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression
por: Liao, Wen-Ting, et al.
Publicado: (2009)

Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
por: Liu, Jian-Ye, et al.
Publicado: (2013)

Upregulation of Arp2 expression is associated with the prognosis and prediction of lymph node metastasis in bladder urothelial carcinoma
por: Xu, Ning, et al.
Publicado: (2018)

Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma
por: Wu, Fan, et al.
Publicado: (2017)

Overexpression of Citron Rho-Interacting Serine/Threonine Kinase Associated with Poor Outcome in Bladder Cancer
por: Shou, Jiafeng, et al.
Publicado: (2020)

Increased Renal Versican Expression Is Associated with Progression of Chronic Kidney Disease
por: Rudnicki, Michael, et al.
Publicado: (2012)

Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma
por: Shan, Ying, et al.
Publicado: (2017)

High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer
por: Liu, Pan, et al.
Publicado: (2020)

High expression of HEF1 is associated with poor prognosis in urinary bladder carcinoma
por: Zhang, Qi, et al.
Publicado: (2014)

Upregulation of microfibrillar-associated protein 2 is closely associated with tumor angiogenesis and poor prognosis in hepatocellular carcinoma
por: Zhang, Nu, et al.
Publicado: (2021)

Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer
por: Chang, Wenjing, et al.
Publicado: (2023)

WWP1 upregulation predicts poor prognosis and promotes tumor progression by regulating ubiquitination of NDFIP1 in intrahepatic cholangiocarcinoma
por: Li, Yongjian, et al.
Publicado: (2022)

Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
por: Shao, Xuyang, et al.
Publicado: (2022)

Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation
por: He, Qin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qck211u6kcllpl2bj8vag26btl